These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16911620

  • 21. [Use of modification of diet in renal disease equation in estimating renal insufficiency in type 2 diabetes patients].
    Li Q, Yang M, Bao YQ, Yu HY, Li M, Zhou J, Jia WP, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1966-9. PubMed ID: 19062736
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y, Goto T, Tamasawa N, Matsui J, Tando Y, Sugimoto K, Tomotsune K, Kimura M, Yasujima M, Suda T.
    Diabetes Res Clin Pract; 2008 Feb 22; 79(2):357-61. PubMed ID: 17980929
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
    Li Vecchi M, Fuiano G, Francesco M, Mancuso D, Faga T, Sponton A, Provenzano R, Andreucci M, Tozzo C.
    Nephron Clin Pract; 2007 Feb 22; 105(2):c62-7. PubMed ID: 17135770
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
    Mueller TF, Raeder J, Oettl K, Zitta S, Klausmann G, Estelberger W, Luyckx VA, Reibnegger G.
    Ren Fail; 2008 Feb 22; 30(1):21-9. PubMed ID: 18197539
    [Abstract] [Full Text] [Related]

  • 29. [Prevalence of subnormal glomerular filtration rate in patients with diabetes mellitus].
    Trofimenko II, Dobronravov VA, Bystrova NN, Drozdova IuV, Galkina OV, Smirnov AV.
    Ter Arkh; 2008 Feb 22; 80(6):48-52. PubMed ID: 18655476
    [Abstract] [Full Text] [Related]

  • 30. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y, Doi Y, Hamano T, Hatazaki M, Umayahara Y, Isaka Y, Tsubakihara Y.
    Sci Rep; 2019 Oct 16; 9(1):14871. PubMed ID: 31619722
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin depletion and anaemia in diabetes mellitus.
    Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ.
    Diabet Med; 1999 Oct 16; 16(10):813-9. PubMed ID: 10547207
    [Abstract] [Full Text] [Related]

  • 32. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16.
    Yokoyama H, Oishi M, Kawai K, Sone H, Japan Diabetes Clinical Data Management Study Group.
    Diabet Med; 2008 Dec 16; 25(12):1426-32. PubMed ID: 19046241
    [Abstract] [Full Text] [Related]

  • 33. GFR estimated from cystatin C versus creatinine in children born small for gestational age.
    Franco MC, Nishida SK, Sesso R.
    Am J Kidney Dis; 2008 Jun 16; 51(6):925-32. PubMed ID: 18455848
    [Abstract] [Full Text] [Related]

  • 34. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
    Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L.
    Eur Heart J; 2005 Nov 16; 26(21):2232-7. PubMed ID: 15987710
    [Abstract] [Full Text] [Related]

  • 35. Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function.
    Toffaletti JG, McDonnell EH.
    Clin Chim Acta; 2008 Sep 16; 395(1-2):115-9. PubMed ID: 18573244
    [Abstract] [Full Text] [Related]

  • 36. [Chronic renal disease in diabetic and prediabetic subjects: a community-based study in Shanghai].
    Wang WX, Jia WP, Bao YQ, Lu JX, Lu HJ, Zuo YH, Du J, Liu LH, Fang R, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 26; 86(36):2527-32. PubMed ID: 17198559
    [Abstract] [Full Text] [Related]

  • 37. New predictive equations improve monitoring of kidney function in patients with diabetes.
    Beauvieux MC, Le Moigne F, Lasseur C, Raffaitin C, Perlemoine C, Barthe N, Chauveau P, Combe C, Gin H, Rigalleau V.
    Diabetes Care; 2007 Aug 26; 30(8):1988-94. PubMed ID: 17536079
    [Abstract] [Full Text] [Related]

  • 38. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May 26; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Japan Diabetes Clinical Data Management Study Group.
    Nephrol Dial Transplant; 2009 Apr 26; 24(4):1212-9. PubMed ID: 18984626
    [Abstract] [Full Text] [Related]

  • 40. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
    Rigalleau V, Beauvieux MC, Le Moigne F, Lasseur C, Chauveau P, Raffaitin C, Perlemoine C, Barthe N, Combe C, Gin H.
    Diabetes Metab; 2008 Nov 26; 34(5):482-9. PubMed ID: 18703370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.